This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Clinical trial NCT03599245 · COMPLETED
Trial details
- NCT number
- NCT03599245
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2025-07-17
- Enrollment
- 1055
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.